XML 90 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 28, 2019
Sep. 29, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income/(loss) $ 1,750 $ 2,374
Adjustments to reconcile net income/(loss) to operating cash flows:    
Depreciation and amortization 737 712
Amortization of postretirement benefit plans prior service costs/(credits) (229) (261)
Equity award compensation expense 26 44
Deferred income tax provision/(benefit) (140) 104
Postemployment benefit plan contributions (23) (64)
Goodwill and intangible asset impairment losses 1,223 451
Nonmonetary currency devaluation 10 131
Loss/(gain) on sale of business (490) 15
Other items, net (34) 20
Changes in current assets and liabilities:    
Trade receivables 138 (2,154)
Inventories (637) (645)
Accounts payable 113 130
Other current assets (73) (103)
Other current liabilities (381) 124
Net cash provided by/(used for) operating activities 1,990 878
CASH FLOWS FROM INVESTING ACTIVITIES:    
Cash receipts on sold receivables 0 1,296
Capital expenditures (581) (594)
Payments to acquire business, net of cash acquired (199) (248)
Proceeds from sale of business, net of cash disposed 1,875 18
Other investing activities, net 16 13
Net cash provided by/(used for) investing activities 1,111 485
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments of long-term debt (3,272) (2,706)
Proceeds from issuance of long-term debt 2,967 2,990
Debt prepayment and extinguishment costs (91) 0
Proceeds from issuance of commercial paper 377 2,485
Repayments of commercial paper (377) (1,950)
Dividends paid (1,464) (2,421)
Other financing activities, net (21) (35)
Net cash provided by/(used for) financing activities (1,881) (1,637)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (40) (128)
Cash, cash equivalents, and restricted cash    
Net increase/(decrease) 1,180 (402)
Balance at beginning of period 1,136 1,769
Balance at end of period 2,316 1,367
Non-cash investing activities:    
Beneficial interest obtained in exchange for securitized trade receivables $ 0 $ 938